- To correlate real-world results of:
- Bethesda (BDC) classification
- Mutation panel (ThyGENX®)
- Two-tiered (positive, negative) miRNA classifier (ThyraMIR®)
- To examine the projected real-world absolute risk of cancer of BDC III and BDC IV nodules given mutation panel and miRNA classifier results
The utility of combined mutations and microRNA expression profiling in assessing cancer risk in thyroid nodules
ATA 2017, Victoria, BC, Canada
